https://www.bluekitbio.com/about-bluekit-event/academician-zhang-dan-of-hillgene-was-invited-to-attend-and-make-his-presentation-at-the-22nd-taihu-economic-and-trade-cooperation-meeting-of-wuzhong-district/ 2022-11-03T10:00:36Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-won-the-biocon-awards-annual-cdmo-excellence-award/ 2022-09-13T10:11:48Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-was-awarded-the-top-10-most-promising-cxo-companies-of-china-biopharmaceutical-industry-in-2022/ 2022-08-15T10:23:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-event/the-cell-world-1st-global-cell-therapy-summit-and-hillgene-biopharma-anniversary-celebration/ 2023-05-29T10:30:25Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/dr-yuan-zhao-was-appointed-as-the-chief-technology-officer-of-cdmo-responsible-for-innovative-research-and-development-and-the-construction-of-international-standard-quality-system/ 2023-05-29T00:00:00Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-biopharma-selected-in-kpmg-china-s-2nd-biotechnology-50-list-/ 2023-05-29T00:00:00Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-biopharma-won-the-2022ebc-annual-most-popular-products-top100/ 2023-03-21T00:00:00Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-biopharma-won-the-2022-china-biomedicine-industry-chain-innovation-ranking-the-most-concerned-new-enterprises-golden-horse-award/ 2023-02-17T00:00:00Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hillgene-biopharma-was-awarded-the-vb-find-award2022-top100-most-innovative-medical-technology-products/ 2022-12-19T00:00:00Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-event/test/ 2023-11-09T14:12:46Z 0.9 weekly https://www.bluekitbio.com/technical-articles/e-coli-residual-dna-detection-kit-qpcr-/ 2024-01-11T10:31:30Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/how-do-you-isolate-dna-from-e-coli-/ 2024-09-05T14:47:03Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-residual-dna-testing-/ 2024-09-23T14:17:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-residual-dna-/ 2024-09-25T14:38:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-genomic-dna-kit-/ 2024-09-27T14:40:06Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/how-to-choose-the-right-mycoplasma-test-kit-/ 2024-12-03T14:38:02Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-are-the-steps-involved-in-genomic-dna-extraction-/ 2024-12-05T15:07:02Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-crs-cytokine-multiplex-elisa-kit-/ 2024-12-07T15:26:02Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-human-il-2-detection-kit-/ 2024-12-09T15:26:03Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/exploring-the-bluekit-kanamycin-elisa-kit/ 2024-12-11T15:31:02Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/harnessing-the-power-of-nk-cells-revolutionizing-cell-therapy/ 2024-12-13T15:31:09Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/pioneering-the-future-of-hiv-detection-advanced-p24-elisa-kit-technologies/ 2024-12-15T15:32:08Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/bluekit-s-il-15-elisa-kit-in-immunological-research/ 2024-12-17T15:41:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/safety-compliance-e-coli-rna-detection-with-taqman-probe/ 2025-02-19T10:54:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/innovations-in-e-coli-rna-kits-for-cell-therapy/ 2025-02-22T11:22:03Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/drug-safety-kanamycin-residual-detection/ 2025-02-25T11:44:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/the-role-of-gene-copy-number-kits-in-modern-science/ 2025-02-28T11:58:07Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/hiv-1-p24-detection-bluekit-solutions/ 2025-03-03T12:07:06Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/role-of-293t-hcp-elisa-kits-in-biopharmaceutical-safety/ 2025-03-06T12:38:07Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/revolutionizing-medicine-the-role-of-plasmid-dna-in-cell-therapy/ 2025-03-28T11:09:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/elevating-scientific-research-the-comprehensive-role-of-bsa-kits/ 2025-04-03T11:43:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/bluekit-trypsin-kits-powering-life-science-innovations/ 2025-04-09T11:47:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/revolutionizing-genomic-research-the-future-of-dna-extraction/ 2025-05-15T17:08:12Z 0.9 weekly https://www.bluekitbio.com/industry-information/merus-drug-with-immunotherapy-shows-preliminary-survival-boost-for-patients-with-head-and-neck-cancer/ 2025-05-26T14:12:50Z 0.9 weekly https://www.bluekitbio.com/industry-information/four-ways-the-covid-causing-virus-changed-science/ 2025-05-26T14:12:15Z 0.9 weekly https://www.bluekitbio.com/industry-information/fda-asks-mrna-vaccine-makers-to-widen-age-range-for-rare-heart-risk-warning/ 2025-05-26T14:11:03Z 0.9 weekly https://www.bluekitbio.com/regulation-guildeline/regulation-guidelines-for-bluekitbio-cell-therapy-testing-reagents/ 2025-05-26T14:25:27Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-we-know-about-the-safety-efficacy-of-mrna-vaccines-amid-recent-scrutiny/ 2025-05-29T17:32:49Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/the-transformative-impact-of-integrated-informatics-platforms-on-biopharma-r-d/ 2025-05-30T11:15:48Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/glycoera-raises-130m-riding-interest-in-protein-degraders/ 2025-05-30T11:27:02Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/fda-panel-recommends-keeping-covid-shots-targeted-to-same-strain-as-last-year/ 2025-05-30T11:34:14Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/pfizer-buys-into-pd-1-vegf-competition-with-3sbio-deal/ 2025-05-30T11:40:57Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-temperature-is-optimal-for-benzonase-activity-/ 2025-08-26T18:11:15Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-benzonase-used-for-/ 2025-08-16T17:58:04Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/how-does-plasmid-dna-production-support-vaccine-development-/ 2025-08-26T18:14:49Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-components-are-included-in-a-bsa-kit-/ 2025-09-01T18:38:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-is-the-difference-between-trypsin-and-other-proteases-/ 2025-09-09T19:31:05Z 0.9 weekly https://www.bluekitbio.com/about-bluekit-news/what-are-the-benefits-of-using-a-bca-kit-/ 2025-09-17T20:14:05Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/what-is-the-purpose-of-using-alcohol-in-dna-extraction-/ 2025-09-28T14:11:07Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/what-components-are-included-in-a-car-kit-/ 2025-09-29T14:49:11Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/what-is-an-rcl-detection-kit-used-for-/ 2025-11-18T15:05:27Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/bluekit-featured-product-rapid-lentiviral-p24-elisa-titer-assay-kit/ 2025-11-18T17:33:58Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/professor-raju-kucherlapati-visits-hillgene-exploring-opportunities-and-challenges-in-the-car-t-revolution-of-the-precision-medicine-era/ 2025-11-18T17:33:25Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/event-review-academician-zhang-dan-was-invited-to-attend-2025-csgct-and-talked-about-a-new-way-out-of-cell-therapy/ 2025-11-18T17:38:42Z 0.9 weekly https://www.hillgenebio.com/about-bluekit-news/hillgene-takes-note-of-fda-new-guidelines-interpreting-the-latest-developments-and-industry-opportunities-in-cross-border-genetic-data-research/ 2025-11-21T11:52:18Z 0.9 weekly https://www.hillgenebio.com/resources/ucb-completes-acquisition-of-neurona-therapeutics-expanding-into-regenerative-cell-therapy/ 2026-06-17T15:04:32Z 0.9 weekly https://www.hillgenebio.com/resources/gsk-to-acquire-nuvalent-for-10-6-billion-strengthening-its-oncology-pipeline/ 2026-06-17T15:08:42Z 0.9 weekly https://www.hillgenebio.com/resources/professor-raju-kucherlapati-visits-hillgene-exploring-opportunities-and-challenges-in-the-car-t-revolution-of-the-precision-medicine-era/ 2026-06-17T15:08:58Z 0.9 weekly https://www.hillgenebio.com/resources/in-vivo-car-t-gains-momentum-as-early-clinical-data-show-promise-in-lymphoma/ 2026-06-17T15:11:55Z 0.9 weekly https://www.hillgenebio.com/resources/fda-s-new-draft-guidance-highlights-the-growing-value-of-platform-knowledge-in-gene-therapy-development/ 2026-06-17T15:15:34Z 0.9 weekly https://www.hillgenebio.com/resources/next-generation-aav-capsids-aim-to-improve-safety-and-efficiency-in-gene-therapy/ 2026-06-17T15:28:07Z 0.9 weekly https://www.hillgenebio.com/resources/kolon-life-science-secures-singapore-manufacturing-patent-for-tg-c-cell-and-gene-therapy/ 2026-06-17T16:22:35Z 0.9 weekly https://www.hillgenebio.com/resources/china-s-first-solid-tumor-car-t-approved-a-full-landscape-review-of-cldn18-2-targeted-therapies/ 2026-06-23T15:22:02Z 0.9 weekly https://www.hillgenebio.com/resources/shanghai-releases-25-cgt-industry-policies-empowering-end-to-end-biopharma-productivity/ 2026-06-25T17:45:43Z 0.9 weekly https://www.hillgenebio.com/resources/fda-approves-orca-t-tregzi-a-new-precision-cell-therapy-reducing-post-transplant-complications-in-blood-cancer-patients/ 2026-07-01T15:32:48Z 0.9 weekly https://www.hillgenebio.com/industry-information/ipsen-to-acquire-memo-therapeutics-in-deal-worth-up-to-800-million-expanding-rare-disease-portfolio/ 2026-07-03T16:53:42Z 0.9 weekly https://www.hillgenebio.com/industry-information/fda-expands-casgevy-approval-to-children-as-young-as-two-marking-a-new-milestone-for-crispr-gene-editing/ 2026-07-06T16:34:36Z 0.9 weekly https://www.hillgenebio.com/resources/fda-expands-casgevy-approval-to-children-as-young-as-two-marking-a-new-milestone-for-crispr-gene-editing/ 2026-07-06T16:36:04Z 0.9 weekly